Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-26

Clinical Trial Update: Booster Vaccination in Preventing Disease Recurrence in Previously Vaccinated Patients With Melanoma That Has Been Removed By Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated whether a booster vaccination could prevent recurrence of surgically removed melanoma in patients who had prior vaccination; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Melanoma, Stage IA Skin Melanoma | Phase 1 | Status: COMPLETED